Notice: This company has been marked as potentially delisted and may not be actively trading. Gamida Cell (GMDA) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGMDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMDA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad GreenlaneThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here. Gamida Cell Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.32)($0.07)($0.20)Q2 20241($0.05)($0.05)($0.05)Q3 20241($0.03)($0.03)($0.03)Q4 20241$0.04$0.04$0.04FY 20245($0.36)($0.11)($0.24) Get Gamida Cell Earnings AlertsEnter your email address below to receive the latest news and earnings results for GMDA and its competitors with MarketBeat's FREE daily newsletter. Gamida Cell Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks11/14/2023Q3 2023($0.15)($0.01)+$0.14($0.01)$3.24 million$0.67 million8/14/2023Q2 2023($0.18)($0.31)($0.13)($0.31)-- 5/15/2023Q1 2023($0.27)($0.27)-($0.27)--3/27/2023Q4 2022($0.24)($0.29)($0.05)($0.87)--11/14/2022Q3 2022($0.31)($0.29)+$0.02($0.29)-- 8/15/2022Q2 2022($0.31)($0.31)-($0.31)-- Get the Latest News and Ratings for GMDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter. 5/10/2022Q1 2022($0.34)($0.34)-($0.34)-- 3/15/2022Q4 2021($0.44)($0.34)+$0.10($0.34)-- 11/15/2021Q3 2021($0.48)($0.33)+$0.15($0.33)-- 8/10/2021Q2 2021($0.40)($0.36)+$0.04($0.42)-- 5/10/2021Q1 2021($0.40)($0.31)+$0.09($0.34)-- 3/8/2021Q4 2020($0.34)($0.68)($0.34)($0.68)-- 11/15/2020Q3 2020($0.31)($0.30)+$0.01($0.30)-- 8/11/2020Q2 2020($0.26)($0.37)($0.11)($0.37)-- 5/21/2020Q1($0.43)($0.31)+$0.12($0.31)-- 2/25/2020Q4($0.39)($0.31)+$0.08($0.45)-- 11/13/2019Q3($0.37)($0.30)+$0.07($0.30)-- Gamida Cell Earnings - Frequently Asked Questions How much revenue does Gamida Cell generate each year? Gamida Cell (NASDAQ:GMDA) has a recorded annual revenue of $1.78 million. How much profit does Gamida Cell generate each year? Gamida Cell (NASDAQ:GMDA) has a recorded net income of -$63 million. GMDA has generated -$0.63 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: NKGen Biotech Earnings Date Cyclo Therapeutics Earnings Date Finch Therapeutics Group Earnings Date Evaxion Biotech A/S Earnings Date PharmaCyte Biotech Earnings Date AIM ImmunoTech Earnings Date Turnstone Biologics Earnings Date IN8bio Earnings Date Senti Biosciences Earnings Date Inhibikase Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:GMDA) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gamida Cell Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gamida Cell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.